Login

RAPT Therapeutics, Inc. SEC Filings

Filed On Filing
15 May 2026 SCHEDULE 13G/A
15 May 2026 SCHEDULE 13G/A
18 Mar 2026 15-12G
05 Mar 2026 Form 4: Lyons-Williams Lori, Director

Disposed of 4,956 shares (Tender Offer) · Disposed of 42,284 Director Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Gray Mary Ann, Director

Disposed of 4,956 shares (Tender Offer) · Disposed of 54,902 Director Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Giordano Michael F, Director

Disposed of 4,956 shares (Tender Offer) · Disposed of 43,372 Director Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Dombkowski Ashley L., Director

Disposed of 4,956 shares (Tender Offer) · Disposed of 25,000 Director Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Young Rodney Kb, CHIEF FINANCIAL OFFICER

Disposed of 3,304 shares (Tender Offer) · Disposed of 202,399 Employee Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Brockstedt Dirk G., CHIEF SCIENTIFIC OFFICER

Disposed of 4,648 shares (Tender Offer) · Disposed of 160,094 Employee Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Wong Brian Russell, Director

Disposed of 64,102 shares (Tender Offer) · Disposed of 763,251 Employee Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Kozick Linda, Director

Disposed of 4,956 shares (Tender Offer) · Disposed of 46,806 Director Stock Option (right to buy) (Disposition to Issuer)

05 Mar 2026 Form 4: Braunstein Scott, Director

Disposed of 4,956 shares (Tender Offer) · Disposed of 25,000 Director Stock Option (right to buy) (Disposition to Issuer)

04 Mar 2026 EFFECT
04 Mar 2026 EFFECT
03 Mar 2026 POS AM
03 Mar 2026 POS AM
03 Mar 2026 S-8 POS
03 Mar 2026 S-8 POS
03 Mar 2026 S-8 POS
03 Mar 2026 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support